title: A national profile of Tourette syndrome, 2011-2012.
abstract: OBJECTIVE
  To provide recent estimates of the prevalence of Tourette syndrome among a nationally representative sample of US children and to describe the association of Tourette syndrome with indicators of health and functioning.
  
  
  METHODS
  Data on 65,540 US children aged 6 to 17 years from the 2011-2012 National Survey of Children's Health were analyzed. Parents reported whether a health care provider had ever told them their child had Tourette syndrome or other neurobehavioral or chronic health conditions and whether their child had current Tourette syndrome.
  
  
  RESULTS
  Based on parents' report, 0.19% of US children had Tourette syndrome; the average age of diagnosis was 8.1 years. Children with Tourette syndrome, compared with those without, were more likely to have co-occurring neurobehavioral and other health conditions, meet criteria for designation as having a special health care need, receive mental health treatment, have unmet mental health care needs, and have parents with high parenting aggravation and parents who were contacted about school problems; they were less likely to receive effective care coordination or have a medical home. After controlling for co-occurring neurobehavioral conditions, the findings on parents being contacted about school problems and children having unmet mental health care needs were no longer significant.
  
  
  CONCLUSIONS
  Tourette syndrome is characterized by co-occurring neurobehavioral and other health conditions, and poorer health, education, and family relationships. The findings support previous recommendations to consider co-occurring conditions in the diagnosis and treatment of Tourette syndrome. Future research may explore whether having a medical home improves outcomes among children with Tourette syndrome.
authors.affiliation: *Division of Human Development and Disability, National Center on Birth Defects and Developmental Disabilities (NCBDDD), Centers for Disease Control and Prevention, Atlanta, GA; †Departments of Neurology, Neurobiology and Anatomy, Brain and Cognitive Sciences and Pediatrics, University of Rochester, Rochester, NY; ‡Department of Pediatrics, Division of Developmental Medicine, University of Washington, Seattle, WA; §Office of Epidemiology and Research, Maternal and Child Health Bureau, Health Resources and Services Administration, Rockville, MD; ‖Division of Health Interview Statistics, National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, MD.
authors.forename: Rebecca H
authors.initials: RH
authors.lastname: Bitsko
authors.forename: Joseph R
authors.initials: JR
authors.lastname: Holbrook
authors.forename: Susanna N
authors.initials: SN
authors.lastname: Visser
authors.forename: Jonathan W
authors.initials: JW
authors.lastname: Mink
authors.forename: Samuel H
authors.initials: SH
authors.lastname: Zinner
authors.forename: Reem M
authors.initials: RM
authors.lastname: Ghandour
authors.forename: Stephen J
authors.initials: SJ
authors.lastname: Blumberg
mesh_terms: D000293:Adolescent; D002648:Child; D003430:Cross-Sectional Studies; D005260:Female; D006304:Health Status; D006801:Humans; D064747:Lansoprazole; D008297:Male; D005879:Tourette Syndrome / Q000150:complications / Q000453:epidemiology*; D014481:United States / Q000453:epidemiology
chemical_list: D064747:Lansoprazole